{"id":"hiv-therapy","safety":{"commonSideEffects":[{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Rash"},{"rate":null,"effect":"Lipodystrophy"},{"rate":null,"effect":"Hepatotoxicity"},{"rate":null,"effect":"Renal impairment"}]},"_chembl":{"chemblId":"CHEMBL3672477","moleculeType":"Small molecule","molecularWeight":"317.28"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"ViiV Healthcare manufactures multiple HIV antiretroviral drugs across different drug classes. These agents target distinct steps in the HIV replication cycle: reverse transcriptase inhibitors block conversion of viral RNA to DNA, protease inhibitors prevent maturation of viral particles, integrase inhibitors block insertion of viral DNA into the host genome, and entry inhibitors prevent viral attachment or fusion with CD4+ T cells. Combination antiretroviral therapy (ART) using agents from multiple classes achieves viral suppression and immune reconstitution.","oneSentence":"ViiV Healthcare's HIV therapies work by inhibiting viral replication through various mechanisms including reverse transcriptase inhibition, protease inhibition, integrase inhibition, or entry inhibition, depending on the specific agent.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:23:47.800Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"HIV-1 infection (treatment and prevention)"},{"name":"AIDS (acquired immunodeficiency syndrome)"}]},"trialDetails":[{"nctId":"NCT07042945","phase":"PHASE1","title":"MK-4646 Multiple Dose Trial in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-4646-003)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-07-09","conditions":"HIV Infection","enrollment":28},{"nctId":"NCT03856229","phase":"NA","title":"Short-term Steroid Therapy in Patients With P. Jirovecii Pneumonia Due to HIV / AIDS","status":"ENROLLING_BY_INVITATION","sponsor":"Centro de Investigación en. Enfermedades Infecciosas, Mexico","startDate":"2019-03-04","conditions":"Pneumocystis, HIV/AIDS, Steroid","enrollment":196},{"nctId":"NCT04929028","phase":"PHASE2","title":"Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2022-08-09","conditions":"AIDS-Related Anal Carcinoma, Anal Margin Squamous Cell Carcinoma, Anal Non-Keratinizing Squamous Cell Carcinoma","enrollment":40},{"nctId":"NCT00980538","phase":"PHASE3","title":"TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Sciences Ireland UC","startDate":"2009-12-09","conditions":"HIV Infections, HIV-1","enrollment":180},{"nctId":"NCT06819176","phase":"PHASE1","title":"Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-01-20","conditions":"Human Immunodeficiency Virus","enrollment":50},{"nctId":"NCT00092222","phase":"PHASE2","title":"Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2004-10-28","conditions":"Lymphoproliferative Disorder, HHV-8, Malignancy","enrollment":75},{"nctId":"NCT00326482","phase":"","title":"Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral Therapy","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2006-07-31","conditions":"Liver Fibrosis, Steatohepatitis, Elevated Transaminases","enrollment":127},{"nctId":"NCT04304768","phase":"PHASE4","title":"Opioid, HIV and Immune System","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Miami","startDate":"2020-11-18","conditions":"Immune Defect","enrollment":400},{"nctId":"NCT04223791","phase":"PHASE3","title":"Switch to Doravirine/Islatravir (DOR/ISL) in Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-018)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-02-18","conditions":"HIV Infection","enrollment":643},{"nctId":"NCT06880705","phase":"NA","title":"The Trans-Led Care Study","status":"RECRUITING","sponsor":"Illinois Institute of Technology","startDate":"2025-02-10","conditions":"Substance Abuse, Substance Addiction, Substance Use Disorder (SUD)","enrollment":124},{"nctId":"NCT07308886","phase":"PHASE2","title":"Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-04-01","conditions":"Kaposi Sarcoma","enrollment":55},{"nctId":"NCT07402044","phase":"","title":"CABOTEGRAVIR/LENACAPAVIR DUAL LONG ACTING THERAPY (COHORT IMEA 074)","status":"NOT_YET_RECRUITING","sponsor":"Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba","startDate":"2026-03-15","conditions":"CABOTEGRAVIR, LENACAPAVIR","enrollment":50},{"nctId":"NCT05419024","phase":"PHASE2","title":"Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-01-09","conditions":"HIV","enrollment":50},{"nctId":"NCT05165810","phase":"NA","title":"Evaluation of Multiple Interventions to Improve HIV Treatment Outcomes Among People Who Inject Drugs in India","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2023-03-09","conditions":"HIV Infections","enrollment":800},{"nctId":"NCT00039689","phase":"","title":"Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2002-07-12","conditions":"HIV","enrollment":750},{"nctId":"NCT05680948","phase":"","title":"Extended Follow-Up of the ISS T-003 Trial Volunteers (ISS T-003 EF-UP2020)","status":"COMPLETED","sponsor":"Istituto Superiore di Sanità","startDate":"2023-01-25","conditions":"HIV Infections","enrollment":179},{"nctId":"NCT04975698","phase":"PHASE2","title":"HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903","status":"COMPLETED","sponsor":"Catherine Bollard","startDate":"2021-10-25","conditions":"HIV Associated Lymphoma","enrollment":12},{"nctId":"NCT04303117","phase":"PHASE1, PHASE2","title":"PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-07-13","conditions":"Kaposi Sarcoma","enrollment":80},{"nctId":"NCT04930744","phase":"PHASE2","title":"Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)","status":"COMPLETED","sponsor":"University of Massachusetts, Worcester","startDate":"2021-08-26","conditions":"Tuberculosis, Pulmonary Tuberculosis, HIV Coinfection","enrollment":112},{"nctId":"NCT05510908","phase":"","title":"Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC","status":"COMPLETED","sponsor":"AIDS Malignancy Consortium","startDate":"2023-07-25","conditions":"HIV-Associated Malignant Neoplasm, HIV Infections, Cancer","enrollment":460},{"nctId":"NCT07144293","phase":"PHASE2","title":"Improving Physical Ability and Cellular Senescence Elimination in HIV","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-12-04","conditions":"HIV, Frailty, Prefrail","enrollment":82},{"nctId":"NCT06593080","phase":"NA","title":"The DECIDE-TB Trial; Validation of Treatment Decision Algorithms for Childhood Tuberculosis","status":"RECRUITING","sponsor":"Chishala Chabala","startDate":"2024-06-01","conditions":"Tuberculosis, Child Health, HIV","enrollment":30240},{"nctId":"NCT01842386","phase":"PHASE1","title":"Rituximab for Anti-cytokine Autoantibody-Associated Diseases","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2014-04-29","conditions":"Pulmonary Alveolar Proteinosis (PAP), Severe Mucocutaneous Candidiasis","enrollment":7},{"nctId":"NCT07053384","phase":"PHASE1","title":"A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV","status":"ACTIVE_NOT_RECRUITING","sponsor":"ViiV Healthcare","startDate":"2025-07-10","conditions":"HIV Infections","enrollment":107},{"nctId":"NCT06398847","phase":"NA","title":"Virtual Reality (VR) Self-Hypnosis Software","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2026-05-29","conditions":"Musculoskeletal Pain, Neuropathic Pain, Neuralgia","enrollment":25},{"nctId":"NCT04514484","phase":"PHASE1","title":"Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-11-22","conditions":"Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma","enrollment":8},{"nctId":"NCT04704648","phase":"NA","title":"Feasibility Study of Ocular Surface Squamous Neoplasia Surgical Excision in People Living With HIV in Sub-Saharan Africa","status":"RECRUITING","sponsor":"AIDS Malignancy Consortium","startDate":"2023-06-21","conditions":"Ocular Surface Squamous Neoplasia, HPV","enrollment":84},{"nctId":"NCT07194902","phase":"NA","title":"HIV Self-testing for Partners of HIV-uninfected Postpartum Women","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2026-03-19","conditions":"HIV Self-testing, Male Partners of HIV-negative Postpartum Women, PrEP Uptake","enrollment":120},{"nctId":"NCT07062614","phase":"","title":"Exploration of the Variability of Exposure to Antiretroviral Treatment in Hair With a View to Validating Its Value as a Diagnostic Tool for Partial and/or Total Non-compliance With Treatment","status":"RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2025-07-03","conditions":"HIV (Human Immunodeficiency Virus)","enrollment":30},{"nctId":"NCT02016924","phase":"PHASE2, PHASE3","title":"Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gilead Sciences","startDate":"2014-01-16","conditions":"Acquired Immune Deficiency Syndrome (AIDS), HIV Infections","enrollment":133},{"nctId":"NCT05917210","phase":"NA","title":"Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda","status":"RECRUITING","sponsor":"Yale University","startDate":"2026-03-16","conditions":"Tuberculosis, HIV","enrollment":1920},{"nctId":"NCT04532970","phase":"NA","title":"BAPS in Botswana: The Thotloetso Trial","status":"COMPLETED","sponsor":"Abramson Cancer Center at Penn Medicine","startDate":"2021-05-06","conditions":"HIV Infections, Smoking Cessation, Smoking","enrollment":651},{"nctId":"NCT01571752","phase":"","title":"Health Outcomes by Neighborhood - Baltimore","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2012-07-17","conditions":"Stigma, Activity Space, Social Networks","enrollment":1651},{"nctId":"NCT05994742","phase":"PHASE3","title":"An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM","status":"ACTIVE_NOT_RECRUITING","sponsor":"Queen Mary University of London","startDate":"2024-07-15","conditions":"Severe Acute Malnutrition, HIV, Comorbidities and Coexisting Conditions","enrollment":674},{"nctId":"NCT07392372","phase":"PHASE1","title":"A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV","status":"RECRUITING","sponsor":"BioNTech SE","startDate":"2026-02-09","conditions":"HIV -1 Infection","enrollment":61},{"nctId":"NCT05140421","phase":"NA","title":"Testing a Novel Data-to-Suppression (D2S) Intervention Strategy in the Ryan White HIV/AIDS Program","status":"ACTIVE_NOT_RECRUITING","sponsor":"City University of New York","startDate":"2021-12-15","conditions":"Hiv","enrollment":1494},{"nctId":"NCT00001471","phase":"","title":"Tissue Biopsy and Imaging Studies in HIV-Infected Patients","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"1994-11-30","conditions":"HIV, ICL, Healthy Volunteers","enrollment":386},{"nctId":"NCT05907759","phase":"PHASE2","title":"Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-07-10","conditions":"Lymphoma, Primary Effusion","enrollment":28},{"nctId":"NCT05479760","phase":"NA","title":"KP-Led Same Day HCV Test and Treat Study","status":"COMPLETED","sponsor":"Institute of HIV Research and Innovation Foundation, Thailand","startDate":"2023-08-17","conditions":"HCV, HIV","enrollment":200},{"nctId":"NCT05055596","phase":"NA","title":"Improving Quality of Life for Adults Living With HIV and Chronic Pain","status":"COMPLETED","sponsor":"Temple University","startDate":"2021-11-30","conditions":"HIV Infections, Chronic Pain","enrollment":36},{"nctId":"NCT04645693","phase":"","title":"The Impact of Oral Health in HIV Patients on Antiretroviral Therapy","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2021-02-24","conditions":"HIV, Periodontal Diseases, Caries","enrollment":227},{"nctId":"NCT02129244","phase":"NA","title":"A Nurse Case Management Intervention to Improve MDR-TB/HIV Co-Infection Outcomes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2014-10","conditions":"MDR-TB, HIV","enrollment":3600},{"nctId":"NCT06823596","phase":"NA","title":"The T Cell Activator of Cell Killing (\"TACK\") IT ON\" STUDY","status":"RECRUITING","sponsor":"University of Toronto","startDate":"2025-01-14","conditions":"Hiv","enrollment":26},{"nctId":"NCT07133555","phase":"NA","title":"Safe Spaces 4 Sexual Health","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2025-08-10","conditions":"HIV Counseling and Testing, HIV Risk Behavior, HIV Prevention","enrollment":100},{"nctId":"NCT07476339","phase":"PHASE4","title":"REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE: A Multi-Center, Single-Arm, Open-Label, Phase 4 Study Assessing the Safety and Efficacy of B/F/TAF in HIV-Positive Adults Returning to Care After Experiencing a Treatment Interruption of ≥12 Weeks","status":"NOT_YET_RECRUITING","sponsor":"CAN Community Health","startDate":"2026-03-23","conditions":"HIV -1 Infection, HIV (Human Immunodeficiency Virus), HIV","enrollment":200},{"nctId":"NCT04499053","phase":"PHASE2","title":"Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer","status":"RECRUITING","sponsor":"Georgetown University","startDate":"2020-12-09","conditions":"Carcinoma, Non-Small Cell Lung","enrollment":18},{"nctId":"NCT05612178","phase":"PHASE1","title":"A Study to Evaluate the Safety and Effects of Repeated Doses of 3BNC117-LS and 10-1074-LS on Persistent Viral Reservoirs in People Living With HIV and on Suppressive Antiretroviral Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2023-07-26","conditions":"HIV-1","enrollment":105},{"nctId":"NCT06337032","phase":"PHASE4","title":"A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments","status":"RECRUITING","sponsor":"Gilead Sciences","startDate":"2024-08-27","conditions":"HIV-1-infection","enrollment":350},{"nctId":"NCT07270406","phase":"NA","title":"Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2026-02-16","conditions":"Chronic Pain, Insomnia, HIV","enrollment":200},{"nctId":"NCT05390541","phase":"NA","title":"Increasing HIV/STI Home Testing Via a Digital Intervention Among Black Women","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2022-02-02","conditions":"Hiv, Sexually Transmitted Diseases, Economic Problems","enrollment":3},{"nctId":"NCT04860323","phase":"NA","title":"Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 703/HPTN 081 AMP Study","status":"COMPLETED","sponsor":"HIV Vaccine Trials Network","startDate":"2021-05-28","conditions":"HIV Infection","enrollment":13},{"nctId":"NCT07125235","phase":"NA","title":"Reactive Driven Support for Treatment, Adherence, Resilience, and Thriving (reSTART) Clinical Trial","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2026-02-09","conditions":"Behavioral Intervention, Viral Suppression of HIV Infection, ART Adherence","enrollment":270},{"nctId":"NCT04902443","phase":"PHASE1","title":"Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-12-10","conditions":"Viral Associated Malignancies, Kaposi Sarcoma, EBV/KSHV-associated Lymphomas","enrollment":58},{"nctId":"NCT05075967","phase":"NA","title":"Getting to Zero Among HHI MSM in the American South","status":"ENROLLING_BY_INVITATION","sponsor":"HIV Prevention Trials Network","startDate":"2025-12-10","conditions":"HIV Infections","enrollment":2700},{"nctId":"NCT07466836","phase":"NA","title":"The Effects of Chiropractic Care on Inflammation and Quality of Life in People Living With HIV","status":"NOT_YET_RECRUITING","sponsor":"Tyson Perez, DC, PhD","startDate":"2026-04","conditions":"Human Immunodeficiency Virus (HIV)","enrollment":40},{"nctId":"NCT06052618","phase":"PHASE2","title":"Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2025-03-17","conditions":"KSHV Inflammatory Cytokine Syndrome (KICS), Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease","enrollment":75},{"nctId":"NCT07459218","phase":"NA","title":"IDEAS for Hope to Reduce Suicide Risk and Improve HIV Care Engagement in Tanzania","status":"NOT_YET_RECRUITING","sponsor":"Duke University","startDate":"2026-08-01","conditions":"HIV - Human Immunodeficiency Virus, Suicide Prevention","enrollment":600},{"nctId":"NCT07468695","phase":"NA","title":"Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS2 Kenya","status":"NOT_YET_RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2026-03","conditions":"HIV (Human Immunodeficiency Virus), HPV, Cervical Precancer","enrollment":300},{"nctId":"NCT06835751","phase":"NA","title":"Optimizing HIV Pre-exposure Prophylaxis (PrEP) Among Women Who Use Drugs in Tanzania","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2025-07-25","conditions":"HIV, Mental Health, Substance Use (Drugs, Alcohol)","enrollment":200},{"nctId":"NCT02572323","phase":"PHASE2","title":"Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2017-02-15","conditions":"Mild Cognitive Impairment","enrollment":73},{"nctId":"NCT04153136","phase":"PHASE2","title":"The ENCHANTMENT HIV Study","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2020-09-11","conditions":"HIV/AIDS, Heart Failure With Preserved Ejection Fraction","enrollment":39},{"nctId":"NCT05996471","phase":"PHASE2","title":"A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir Compared to Standard of Care (SOC) in Male and Female Adults Living With Human Immunodeficiency Virus (HIV)","status":"ACTIVE_NOT_RECRUITING","sponsor":"ViiV Healthcare","startDate":"2023-08-17","conditions":"HIV Infections","enrollment":185},{"nctId":"NCT04528732","phase":"NA","title":"Suubi4Stigma: Addressing HIV-Associated Stigma Among Adolescents","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2020-11-26","conditions":"HIV/AIDS","enrollment":89},{"nctId":"NCT07221123","phase":"EARLY_PHASE1","title":"Boosting Olfactory and Sensory Training Study (BOOST)","status":"NOT_YET_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-05-01","conditions":"HIV (Human Immunodeficiency Virus)","enrollment":80},{"nctId":"NCT01419561","phase":"PHASE2","title":"Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2011-09-08","conditions":"KSHV Inflammatory Cytokine Syndrome (KICS), KSHV, HHV-8","enrollment":140},{"nctId":"NCT07376239","phase":"","title":"Quality of Life, Depression and Sexual Function in Men Living With HIV","status":"ENROLLING_BY_INVITATION","sponsor":"Kocaeli University","startDate":"2026-02-03","conditions":"HIV Infections","enrollment":100},{"nctId":"NCT06908083","phase":"PHASE1","title":"Immunologic and Virologic Parameters During Analytical Treatment Interruption Following Combination bNAb Therapy During Suppressive ART","status":"ENROLLING_BY_INVITATION","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-09-08","conditions":"HIV","enrollment":50},{"nctId":"NCT06468995","phase":"NA","title":"Antiviral Long Acting Drugs Landing in People Living With HIV","status":"ACTIVE_NOT_RECRUITING","sponsor":"IRCCS San Raffaele","startDate":"2024-12-02","conditions":"HIV, Antiviral Agents","enrollment":120},{"nctId":"NCT07456332","phase":"NA","title":"Effect on Body Weight Reduction of a Behavioral Intervention on Lifestyle Using a Digital Nutritional Program in People Living With HIV and Metabolic Dysfunction-associated Steatotic Liver Disease","status":"ENROLLING_BY_INVITATION","sponsor":"Hospital Universitari de Bellvitge","startDate":"2025-04-23","conditions":"Metabolic Dysfunction-Associated Steatotic Liver Disease, People Living With HIV, Life Style","enrollment":116},{"nctId":"NCT07024992","phase":"PHASE2","title":"Enhancing Smoking Cessation for African American People Everywhere","status":"NOT_YET_RECRUITING","sponsor":"University of Houston","startDate":"2026-04-01","conditions":"ESCAPE Intervention+NRT, quitSTART Intervention+NRT, CTRL+NRT","enrollment":300},{"nctId":"NCT06253533","phase":"PHASE1","title":"ICVAX as a HIV Therapeutic DNA Vaccine","status":"COMPLETED","sponsor":"Immuno Cure Holding (HK) Limited","startDate":"2023-02-14","conditions":"Human Immunodeficiency Virus, Human Immunodeficiency Virus I Infection","enrollment":45},{"nctId":"NCT06682468","phase":"NA","title":"Achieving Equity in Patient Outcome Reporting for Timely Assessments of Life With HIV and Substance Use","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Chicago","startDate":"2025-02-12","conditions":"Substance Use Disorders, HIV","enrollment":900},{"nctId":"NCT05917509","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Safety, Participant Choice and Preference of an Oral Once-daily Regimen or a Long-acting Injectable Regimen Every Two Months for Treatment of Human Immunodeficiency Virus (HIV-1) in Adults Who Have Not Previously Taken Antiretroviral Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"ViiV Healthcare","startDate":"2023-07-06","conditions":"HIV Infections","enrollment":171},{"nctId":"NCT06694805","phase":"PHASE3","title":"A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1","status":"RECRUITING","sponsor":"ViiV Healthcare","startDate":"2024-12-02","conditions":"HIV Infections","enrollment":332},{"nctId":"NCT06096519","phase":"NA","title":"Effectiveness and Implementation of Text Messaging to Improve HIV Testing in Adolescents","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2024-06-13","conditions":"HIV","enrollment":360},{"nctId":"NCT04230395","phase":"NA","title":"Alcohol Reduction Among People With TB and HIV in India","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2022-09-22","conditions":"Tuberculosis, HIV","enrollment":450},{"nctId":"NCT00767312","phase":"","title":"Analysis of HIV-1 Replication During Antiretroviral Therapy","status":"ENROLLING_BY_INVITATION","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2008-11-17","conditions":"HIV","enrollment":70},{"nctId":"NCT06629753","phase":"NA","title":"Differentiated Service Delivery for Pregnant and Postpartum Women Living With HIV and Their Infants","status":"COMPLETED","sponsor":"Indiana University","startDate":"2024-09-13","conditions":"Hiv, Transmission Vertical, Viremia","enrollment":278},{"nctId":"NCT01125228","phase":"","title":"Effectiveness of Zidovudine vs. Zidovudine Plus Alpha Interferon vs. Interferon for Treatment of HIV","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"1988-10-19","conditions":"HIV","enrollment":180},{"nctId":"NCT05285202","phase":"NA","title":"Clinic-based Versus Hotspot-focused Active TB Case Finding","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2022-06-01","conditions":"Tuberculosis, Pulmonary, Mycobacterium Tuberculosis Infection","enrollment":150000},{"nctId":"NCT07453303","phase":"","title":"Comprehensive Geriatric Assessment in Adults Aged 40 Years and Older Living With HIV","status":"NOT_YET_RECRUITING","sponsor":"Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital","startDate":"2026-03-02","conditions":"Frailty, Sarcopenia","enrollment":80},{"nctId":"NCT06139796","phase":"PHASE1, PHASE2","title":"Pharmacokinetics Safety and Acceptability of DRV/r for Children Living With HIV","status":"WITHDRAWN","sponsor":"PENTA Foundation","startDate":"2025-02-01","conditions":"HIV Infections","enrollment":""},{"nctId":"NCT05993767","phase":"PHASE2","title":"UNIVERSAL 1: Pharmacokinetic Study of a Novel DTG/FTC/TAF Dose Ratio for Children","status":"COMPLETED","sponsor":"PENTA Foundation","startDate":"2024-12-11","conditions":"HIV Infection","enrollment":53},{"nctId":"NCT03133728","phase":"","title":"Diagnosis of HIV and Early Antiretroviral Therapy Initiation Among HIV-1 Infected Infants","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2019-05-30","conditions":"HIV Infections, Hiv","enrollment":1682},{"nctId":"NCT06680479","phase":"PHASE1","title":"Safety and Immunogenicity of Stabilized CH505 TF chTrimer Vaccination in Adults Living With HIV-1 on Suppressive Antiretroviral Therapy","status":"SUSPENDED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-04-01","conditions":"HIV-1","enrollment":30},{"nctId":"NCT07342491","phase":"PHASE1","title":"Dasatinib for HIV-1 Reservoir Reduction","status":"NOT_YET_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-03-02","conditions":"HIV Infections","enrollment":14},{"nctId":"NCT04979728","phase":"","title":"HIV Outpatient Monitoring Evaluation Through Self-collection of Dried Blood Spots","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2021-05-27","conditions":"HIV Treatment, HIV Prevention","enrollment":150},{"nctId":"NCT07443228","phase":"PHASE1","title":"Recombinant Human Interleukin-7 (JL18008) for the Treatment of HIV-Infected Immunological Non-Responders","status":"NOT_YET_RECRUITING","sponsor":"Jecho Biopharmaceuticals Co., Ltd.","startDate":"2026-05-30","conditions":"HIV","enrollment":52},{"nctId":"NCT07428330","phase":"NA","title":"Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV","status":"RECRUITING","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2026-02-03","conditions":"Cervix Cancer, HIV Infections, HPV Infection","enrollment":1600},{"nctId":"NCT04915768","phase":"PHASE1","title":"Evaluating the Safety and Immunogenicity of Stabilized CH505 TF chTrimer in Healthy, HIV-uninfected Adult Participants.","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2023-01-23","conditions":"HIV Infections","enrollment":51},{"nctId":"NCT04305691","phase":"PHASE2","title":"Trial of Ixazomib for Kaposi Sarcoma","status":"RECRUITING","sponsor":"AIDS Malignancy Consortium","startDate":"2023-11-07","conditions":"Kaposi Sarcoma, Skin","enrollment":41},{"nctId":"NCT06857071","phase":"NA","title":"Expanded Social Network Recruitment to HIV Testing (E-SNRHT) Intervention to Locate Undiagnosed Cases and Reduce HIV-related Stigma","status":"RECRUITING","sponsor":"University of Illinois at Chicago","startDate":"2025-09-30","conditions":"Undiagnosed HIV Infection, Populations That Are Reluctant to Test for HIV, Long-term Undiagnosed HIV Infection","enrollment":2480},{"nctId":"NCT07439562","phase":"NA","title":"Choice-Based Support for Adults Starting or Restarting Antiretroviral Therapy in Cape Town, South Africa","status":"NOT_YET_RECRUITING","sponsor":"University of Cape Town","startDate":"2026-02","conditions":"HIV Care Loss to Followup","enrollment":140},{"nctId":"NCT05398185","phase":"NA","title":"WiseApp for Spanish Speakers Living With HIV","status":"RECRUITING","sponsor":"Columbia University","startDate":"2023-03-01","conditions":"HIV Infections, Acquired Immune Deficiency Syndrome, Sexually Transmitted Diseases, Viral","enrollment":248},{"nctId":"NCT07211087","phase":"NA","title":"Improving the Treatment of Depression Among Youth With HIV","status":"NOT_YET_RECRUITING","sponsor":"Rhode Island Hospital","startDate":"2026-04-01","conditions":"Depression Disorders, HIV (Human Immunodeficiency Virus)","enrollment":130},{"nctId":"NCT07439003","phase":"","title":"Behavioral Risk Identification and Decision Guidance for HIV Engagement","status":"NOT_YET_RECRUITING","sponsor":"Boston University","startDate":"2026-03","conditions":"HIV","enrollment":15270},{"nctId":"NCT05866523","phase":"NA","title":"Teamwork Makes the Dream Work","status":"RECRUITING","sponsor":"Loma Linda University","startDate":"2023-10-16","conditions":"HIV Infections, Inpatient Facility Diagnoses","enrollment":250},{"nctId":"NCT05980871","phase":"PHASE4","title":"Treatment Responses of Early Syphilis to Ceftriaxone Plus Doxycycline","status":"TERMINATED","sponsor":"National Taiwan University Hospital","startDate":"2023-03-10","conditions":"Early Syphilis","enrollment":109},{"nctId":"NCT07225530","phase":"NA","title":"Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR)","status":"RECRUITING","sponsor":"Columbia University","startDate":"2026-02-23","conditions":"HIV Infections, HPV Infection, Cervical Cancer","enrollment":600},{"nctId":"NCT07433387","phase":"PHASE1, PHASE2","title":"Exploratory Study of LP-98 for Injection in ART-Naive HIV-Infected Individuals","status":"RECRUITING","sponsor":"Shanxi Kangbao Biological Product Co., Ltd.","startDate":"2026-01-29","conditions":"HIV","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Selzentry, Celsentri"],"phase":"marketed","status":"active","brandName":"HIV therapy","genericName":"HIV therapy","companyName":"ViiV Healthcare","companyId":"viiv-healthcare","modality":"Small molecule","firstApprovalDate":"","aiSummary":"ViiV Healthcare's HIV therapies work by inhibiting viral replication through various mechanisms including reverse transcriptase inhibition, protease inhibition, integrase inhibition, or entry inhibition, depending on the specific agent. Used for HIV-1 infection (treatment and prevention), AIDS (acquired immunodeficiency syndrome).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}